Immediate Impact
34 standout
Citing Papers
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
2025 Standout
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
2025 Standout
Works of Kaitlen Reyes being referenced
A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kaitlen Reyes | 82 | 36 | 16 | 39 | 7 | 112 | |
| Mark Yan | 95 | 42 | 16 | 28 | 8 | 143 | |
| Sascha Kretschmann | 71 | 6 | 9 | 54 | 8 | 98 | |
| J. Bauer | 91 | 28 | 16 | 35 | 5 | 164 | |
| Dan-Arin Silasi | 79 | 7 | 10 | 19 | 7 | 183 | |
| T. Guillaume | 67 | 119 | 4 | 56 | 6 | 174 | |
| Julie Alejo | 39 | 8 | 30 | 57 | 5 | 172 | |
| Elisa Cupelli | 52 | 7 | 18 | 23 | 9 | 137 | |
| Tim Malcolm | 50 | 8 | 9 | 31 | 5 | 118 | |
| S. Gottstein | 52 | 75 | 7 | 55 | 11 | 167 | |
| Max Flogegård | 67 | 51 | 2 | 10 | 8 | 109 |
All Works
Loading papers...